119 related articles for article (PubMed ID: 9695574)
1. [A comparison of the diagnostic value of the virus neutralization reaction and of indirect immunoenzyme analysis using monoclonal antibodies for the intratype differentiation of vaccinal and virulent poliovirus strains].
Nikolaienko IV
Lik Sprava; 1998 May; (3):84-6. PubMed ID: 9695574
[TBL] [Abstract][Full Text] [Related]
2. [A monoclonal antibody panel for the intratypic differentiation of type-2 polioviruses].
Shyrobokov VP; Nikolaienko IV; Kopanytsia LV; Solohub VK; Ivanova OIe
Mikrobiol Z; 1997; 59(6):27-36. PubMed ID: 9511373
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibodies to polioviruses. Production of specific monoclonal antibodies to the Sabin vaccine strains.
Osterhaus AD; van Wezel AL; van Steenis B; Drost GA; Hazendonk TG
Intervirology; 1981; 16(4):218-24. PubMed ID: 6177658
[TBL] [Abstract][Full Text] [Related]
4. Evidence for several unrelated neutralization epitopes of poliovirus, type 1, strain Mahoney, provided by neutralization tests and quantitative enzyme-linked immunosorbent assay (ELISA).
Uhlig H; Rutter G; Dernick R
J Gen Virol; 1983 Dec; 64 ( Pt 12)():2809-12. PubMed ID: 6198443
[TBL] [Abstract][Full Text] [Related]
5. Mapping of type 1 poliovirus neutralization epitopes.
Blondel B; Crainic R; Dufraisse G; Candréa A; Horaud F
Dev Biol Stand; 1985; 60():337-42. PubMed ID: 2412917
[TBL] [Abstract][Full Text] [Related]
6. [Monoclonal antibodies used to differentiate between poliovirus types 1 and 3].
Shirobokov VP; Kopanitsa LV; Nikolaenko IV; Lipatnikova KI; Sologub VK
Mikrobiol Z; 2001; 63(6):42-52. PubMed ID: 11944335
[TBL] [Abstract][Full Text] [Related]
7. Production and characterization of neutralizing monoclonal antibodies against poliovirus type 1, 2, and 3.
Payment P; Trudel M; Thibodeau L; Lecomte J
Can J Microbiol; 1989 May; 35(5):550-3. PubMed ID: 2545322
[TBL] [Abstract][Full Text] [Related]
8. [Application of ELISA for screening McAb against type III polioviruses and its antigenic analysis].
Gu FZ; Wang SH; Sun YY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1985 Oct; 7(5):359-63. PubMed ID: 2421926
[No Abstract] [Full Text] [Related]
9. Use of monoclonal antibodies prepared with Sabin vaccine viruses for the characterization of poliovirus strains isolated in Canada.
Wachmann B; Henning D; Armstrong R; Boucher DW; Contreras G; Furesz J
Dev Biol Stand; 1984; 57():141-9. PubMed ID: 6084605
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibodies of four different specificities for neutralization of type 1 polioviruses.
Humphrey DD; Kew OM; Feorino PM
Infect Immun; 1982 May; 36(2):841-3. PubMed ID: 6282759
[TBL] [Abstract][Full Text] [Related]
11. Natural variation of poliovirus neutralization epitopes.
Crainic R; Couillin P; Blondel B; Cabau N; Boué A; Horodniceanu F
Infect Immun; 1983 Sep; 41(3):1217-25. PubMed ID: 6193066
[TBL] [Abstract][Full Text] [Related]
12. Improvement of methods for intratypic differentiation of polioviruses. III. Neutralization test with cross-adsorbed sera for differentiation between wild and vaccine strains of polioviruses.
Pervikov YV; Chumakov MP; Voroshilova MK; Rubin SG; Savinskaya SS; Gracheva LA
Arch Gesamte Virusforsch; 1974; 46(1-2):71-7. PubMed ID: 4374169
[No Abstract] [Full Text] [Related]
13. Antigenic structure of poliovirus in inactivated vaccines.
Ferguson M; Wood DJ; Minor PD
J Gen Virol; 1993 Apr; 74 ( Pt 4)():685-90. PubMed ID: 7682250
[TBL] [Abstract][Full Text] [Related]
14. Studies of the antigenic variation in poliovirus type 1. Selection and analysis of variant strains with monoclonal antibodies by neutralization.
Thibodeau L; Lacroix M; Lecomte J; Fauvel M
Dev Biol Stand; 1984; 57():157-63. PubMed ID: 6084606
[TBL] [Abstract][Full Text] [Related]
15. Strain differentiation of polioviruses with monoclonal antibodies.
Osterhaus AD; van Wezel AL; Stegmann AJ; van Asten JA; Hazendonk AG
Dev Biol Stand; 1984; 57():135-9. PubMed ID: 6098494
[TBL] [Abstract][Full Text] [Related]
16. Genetic and antigenic variation in type 3 polioviruses: characterization of strains by monoclonal antibodies and T1 oligonucleotide mapping.
Minor PD; Schild GC; Ferguson M; Mackay A; Magrath DI; John A; Yates JP; Spitz M
J Gen Virol; 1982 Aug; 61 (Pt 2)():167-76. PubMed ID: 6181190
[TBL] [Abstract][Full Text] [Related]
17. Antigenic structure of polioviruses of serotypes 1, 2 and 3.
Minor PD; Ferguson M; Evans DM; Almond JW; Icenogle JP
J Gen Virol; 1986 Jul; 67 ( Pt 7)():1283-91. PubMed ID: 2425046
[TBL] [Abstract][Full Text] [Related]
18. Neutralization epitope patterns of poliovirus strains isolated from paralytic cases.
Crainic R; Blondel B; Aubert-Combiescu A; Beytout D; Couillin P; Candrea A; Boué A; Horaud F
Dev Biol Stand; 1984; 57():165-70. PubMed ID: 6084607
[TBL] [Abstract][Full Text] [Related]
19. Improvement of methods for intratypic differentiation of polioviruses. II. Use of strain-specific antisera cross-adsorbed with antigens of heterologous strains in agar gel diffusion precipitation test for differentiation between wild and vaccine strains of poliovirus typess 1,2 and 3.
Rubin SG; Chumakov MP; Savinskaya SS; Pervikov YV; Gracheva LA; Voroshilova MK
Arch Gesamte Virusforsch; 1974; 46(1-2):66-70. PubMed ID: 4374168
[No Abstract] [Full Text] [Related]
20. Application of monoclonal antibodies for the identification of the antigenic site for poliovirus neutralization.
Minor PD; Schild GC; Evans D; Ferguson M; Almond J
Dev Biol Stand; 1984; 57():171-5. PubMed ID: 6084608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
